Skip to main content
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Research Analyzes Overtreatment of Thyroid Cancer With Radioactive Iodine Therapy

View All News

Medscape published a report on research by Ambria Moten, MD, MS, Surgery Resident at Temple University Hospital, and colleagues, that found that about a quarter of all patients with low-risk thyroid cancer are still receiving radioactive iodine (RAI) therapy despite recommendations against its use in the patient population. The research was published in the June issue of Surgical Oncology.